Zahravi Pharmacutical Co (XTEH:DZAH1) Debt-to-Equity : 0.00 (As of . 20)

View and export this data going back to 1990. Start your Free Trial

What is Zahravi Pharmacutical Co Debt-to-Equity?

Zahravi Pharmacutical Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was IRR0.00 Mil. Zahravi Pharmacutical Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was IRR0.00 Mil. Zahravi Pharmacutical Co's Total Stockholders Equity for the quarter that ended in . 20 was IRR0.00 Mil.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Zahravi Pharmacutical Co's Debt-to-Equity or its related term are showing as below:

XTEH:DZAH1's Debt-to-Equity is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 0.3
* Ranked among companies with meaningful Debt-to-Equity only.

Zahravi Pharmacutical Co Debt-to-Equity Historical Data

The historical data trend for Zahravi Pharmacutical Co's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zahravi Pharmacutical Co Debt-to-Equity Chart

Zahravi Pharmacutical Co Annual Data

Trend

Debt-to-Equity

Zahravi Pharmacutical Co Semi-Annual Data

Debt-to-Equity

Competitive Comparison of Zahravi Pharmacutical Co's Debt-to-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, Zahravi Pharmacutical Co's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Zahravi Pharmacutical Co's Debt-to-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zahravi Pharmacutical Co's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Zahravi Pharmacutical Co's Debt-to-Equity falls into.

Zahravi Pharmacutical Co Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Zahravi Pharmacutical Co's Debt to Equity Ratio for the fiscal year that ended in . 20 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(	+	)	/	N/A
	=	N/A

Zahravi Pharmacutical Co's Debt to Equity Ratio for the quarter that ended in . 20 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(	+	)	/
	=	N/A

Zahravi Pharmacutical Co (XTEH:DZAH1) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Zahravi Pharmacutical Co Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Zahravi Pharmacutical Co's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Zahravi Pharmacutical Co (XTEH:DZAH1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zahravi Pharmacutical Co (XTEH:DZAH1) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

18th km of Karaj Special Road, Darupakhsh Street, Darupakhsh Factories, Entrance No. 2, No. 23, Tehran, IRN

Website

http://www.zahravi.com

Zahravi Pharmacutical Co is engaged in the pharmaceutical sector. It produces various tablets, capsules, injections, and soft gel capsules. Some of its products are Cograft, Iminoral, Clexaparin, Roaccutane, and others.

Zahravi Pharmacutical Co (XTEH:DZAH1) Headlines

No Headlines